The Patent Finder

Molecular Signature of Cancer

Wake Forest University

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 5 of these applications claim priority to application 61/041,397, filed Apr 1, 2008. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,290,558Molecular Signature of Cancer
In force
 · High confidence
Wake Forest University Health SciencesIn force
High confidence
US 9,974,830Molecular Signature of Cancer
In force
 · High confidence
Wake Forest University Health SciencesIn force
High confidence
US 8,343,461Molecular Signature of Cancer
In force
 · High confidence
Wake Forest University Health SciencesIn force
High confidence
US 11,207,380Molecular Signature of Cancer
In force
 · High confidence
Wake Forest University Health SciencesIn force
High confidence
US 12,419,934Molecular Signature of Cancer
In force
 · High confidence
Wake Forest University Health SciencesIn force
High confidence
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited